4BIO Strengthens Investment Team

LONDON, 4 November 2024 – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm focused solely on the advanced and emerging therapies sector, announces today the appointments of Dr. Therese (Thera) Liechtenstein as an Investment Director based in Munich and Tay Salimullah as a Venture Partner based in Chicago. Full article HERE